Wesbanco Bank Boosts Danaher Co. Holdings in 2023

March 26, 2023

Trending News ☀️

Wesbanco Bank Inc. has recently boosted their holdings in Danaher Corporation ($NYSE:DHR) in 2023. This move is a direct result of the company’s impressive performance and growth potential. With their increased involvement, Wesbanco Bank Inc. will have the chance to capitalize on Danaher’s success and growth in the coming years. This could potentially provide significant returns on their investment, which could lead to further investment and greater financial stability. Danaher Corporation is known for its dedication to innovation, sustainability, and operational excellence, making it an attractive choice for Wesbanco Bank Inc. With this increased involvement, the bank will be able to take advantage of the opportunities that arise from Danaher’s successes.

Additionally, Wesbanco can keep a close eye on the company’s performance and make adjustments to its portfolio as needed. Overall, this move by Wesbanco Bank Inc. should benefit both parties involved. As an investor, Wesbanco can benefit from the potential for increased returns and financial stability. Meanwhile, Danaher Corporation can benefit from having Wesbanco Bank Inc. as a partner, helping to drive innovation and growth within the company.

Share Price

Media coverage of the company has been mostly positive, and on Friday, the stock opened at $245.1 and closed at $248.2, a modest 0.5% increase from the previous day’s closing price of 246.9. This continued positive trend has no doubt been welcomed news for shareholders and investors in the company. With the move by Wesbanco Bank Inc., Danaher Corporation‘s position as a leader in their sector has been further solidified. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Danaher Corporation. More…

    Total Revenues Net Income Net Margin
    31.47k 7.1k 23.7%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Danaher Corporation. More…

    Operations Investing Financing
    8.52k -2.23k -2.57k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Danaher Corporation. More…

    Total Assets Total Liabilities Book Value Per Share
    84.35k 34.26k 68.77
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Danaher Corporation are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    20.7% 38.5% 27.0%
    FCF Margin ROE ROA
    23.4% 10.9% 6.3%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we have conducted a detailed analysis of DANAHER CORPORATION‘s wellbeing. Our assessment revealed that DANAHER CORPORATION is a medium risk investment, with regards to its financial and business aspects. We have identified three key risk warnings with the company’s income sheet, balance sheet, and cashflow statement. To get a more detailed look at the risks associated with this investment, please register with us and we will be happy to provide further information. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis


  • Peers

    Danaher Corp is a large company that operates in many different industries. Its main competitors are Abingdon Health PLC, Charles River Laboratories International Inc, and Dirui Industrial Co Ltd.

    – Abingdon Health PLC ($LSE:ABDX)

    Abingdon Health is a medical technology company that develops, manufactures, and markets diagnostic products and services for the early detection and monitoring of disease. The company has a market capitalization of 8.22 million as of 2022 and a return on equity of -39.58%. Abingdon Health’s products are used in a variety of settings, including primary care, hospitals, and clinics. The company’s products are designed to provide accurate and actionable information to clinicians to improve patient care and outcomes.

    – Charles River Laboratories International Inc ($NYSE:CRL)

    River Laboratories is a global provider of drug discovery, development and manufacturing services. The company has a market cap of $10.15 billion and a return on equity of 13.86%. River Laboratories offers a range of services to its clients, including preclinical and clinical research, manufacturing and packaging, and analytical testing. The company has a strong focus on quality and compliance, and works with clients to ensure that their products meet all regulatory requirements. River Laboratories is headquartered in Wilmington, Massachusetts.

    – Dirui Industrial Co Ltd ($SZSE:300396)

    Drui Industrial Co Ltd is a company that manufactures and sells medical devices. The company has a market cap of 6.61B as of 2022 and a ROE of 8.7%. The company’s products include medical equipment, such as X-ray machines, ultrasound machines, and CT scanners. The company also manufactures and sells medical supplies, such as gloves, gowns, and masks.

    Summary

    Danaher Corporation, a global science and technology company, has seen positive investor sentiment in 2023. Wesbanco Bank Inc. was one of the largest investors to boost their holdings, with a notable increase in their share price in the past year. Analysts have suggested that the company’s strong competitive position in healthcare, environmental and industrial sectors make it a desirable investment.

    Additionally, their focus on developing efficient and innovative products have proven successful. With further development planned for the near future, many anticipate a continued positive return on investments for Danaher Corporation.

    Recent Posts

    Leave a Comment